Cardiovascular diseases (CVD) remain the leading cause of disease burden, causing one in three deaths worldwide as a result of population growth, population aging and exposure to a broad range of risks, including increasing ...
Sep 24, 2025
0
0
Nearly two-thirds of Americans diagnosed with Alzheimer's disease are women, and they often experience faster cognitive decline than men. The reasons behind this sex gap have largely remained a mystery—until now.
Sep 22, 2025
0
21
The first international trial of an unproven stroke treatment available in the U.S. has concluded that, while harmless, "perispinal" etanercept—injected into the spinal area—is no more effective than an inactive dummy ...
Sep 19, 2025
0
0
When someone has a stroke—a leading worldwide cause of death and disability—time is of the essence. Almost nine out of 10 cases are ischemic strokes, caused by restricted blood flow in the brain, and the current gold-standard ...
Sep 16, 2025
0
139
With limited treatment options for stroke patients available, two UConn researchers are developing an experimental drug that is capable of protecting the brain and improving recovery after a cerebral vascular accident also ...
Sep 12, 2025
0
8
The goal of professional sports has always been to win. Looking good while doing it? That's just a bonus for the gawkers and connoisseurs of bodily form in motion.
Sep 5, 2025
0
0
Given the seriousness and increased frequency of strokes, many studies have been conducted to assess the relationship between hysterectomy and/or bilateral oophorectomy and the risk of stroke, with varying results.
Sep 3, 2025
0
0
An artificial intelligence tool which quickly analyzes brain scans of stroke patients has helped boost chances of full recovery since being launched across England, the public health service said on Tuesday.
Sep 2, 2025
0
0
A Win Ratio analysis confirmed the primary result of the NOAH—AFNET 6 trial and did not find an advantage of anticoagulation with edoxaban over no anticoagulation in patients with device-detected atrial fibrillation. Clinical ...
Sep 1, 2025
0
0
Discontinuing oral anticoagulation (OAC) therapy resulted in a lower risk of a composite of stroke, systemic embolism or major bleeding than continuing OAC therapy in patients who had successful ablation for atrial fibrillation ...
Sep 1, 2025
0
3
